Date	Name	Title	Type	Shares Traded	Price Range
Oct 15, 2008	bloch stephen m	Director	Automatic Sell	3,000	10.54 - 11.50
Jun 29, 2009	palling david	Officer	Automatic Sell	2,500	10.54
Oct 21, 2008	bloch stephen m	Director	Automatic Sell	3,000	10.51
Oct 16, 2008	bloch stephen m	Director	Automatic Sell	3,000	10.51
Oct 21, 2008	patterson matthew r	Officer	Automatic Sell	2,500	10.51
Oct 22, 2008	bloch stephen m	Director	Automatic Sell	3,000	10.48
Feb 15, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	6,900	10.47 - 10.50
Feb 15, 2008	topper james n	Director	Buy	6,900	10.47 - 10.50
Feb 28, 2008	palling david	Officer	Sell	2,500	10.46 - 10.55
Nov 3, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	10.45
Feb 13, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	5,800	10.44 - 10.50
Feb 13, 2008	topper james n	Director	Buy	5,800	10.44 - 10.50
Jul 6, 2009	crowley john f	Officer	Automatic Sell	13,500	10.42 - 11.59
Oct 22, 2008	patterson matthew r	Officer	Automatic Sell	3,100	10.40
Jul 8, 2009	crowley john f	Officer	Automatic Sell	12,900	10.37 - 12.49
Jan 2, 2008	crowley john f	Officer	Automatic Sell	400	10.35
May 1, 2008	crowley john f	Officer	Automatic Sell	5,205	10.34 - 10.88
Jan 2, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	10.34
Feb 4, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	33,823	10.32 - 10.50
Feb 5, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	32,864	10.32 - 10.50
Showing 141-160 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.